Hydrogen Peroxide Medical Miracle by William Campbell Douglass - HTML preview

PLEASE NOTE: This is an HTML preview only and some elements such as links or page numbers may be incorrect.
Download the book in PDF, ePub, Kindle for a complete version.

 

Bibliography

For doctors and scientists interested in verifying the material in this book we recommend the following references:

  1. Oliver TH, Cantab BC, and Murphy DV: Influenzal Pneumonia: The Intravenous Injection of Hydrogen Peroxide. Lancet 1920; 1: 432-433.
  2. Tsai SK, Lee TY, Mok MS: Gas Embolism Produced  by Hydrogen Peroxide Irrigation of an Anal Fistula During Anesthesia. 1985; 63: 316-317.
  3. Shah J, Pedemonte MS, Wilcock MM: Hydrogen Peroxide May Cause Venous Oxygen Embolism. Anesthesiology 1984; 61:631-632.
  4. Sleigh J, Linter SPK: Hazards of Hydrogen Peroxide. 1985; 291:1706.
  5. Meyer CT, Brand M, DeLuca VA, et al: Hydrogen Peroxide Colitis: A Report of Three Patients. J. Clin Gastroenterol 1981; 3:31-35.
  6. Shenep JL, Stokes DC, Hughes WT: Lack of Antibacterial Activity After Intravenous Hydrogen Peroxide Infusion in Experimental Escherichia coli Sepses. Infect. Immun. 1985; 48:607-610.
  7. Dockrell HM and Playfair JH: Killing of Blood-Stage Murine Malaria Parasites by Hydrogen Peroxide. Infect. Immun. 1983; 39:456-459.
  8. Weiss SJ, Young J, LoBuglio A, et al: Role of Hydrogen Peroxide in Neutrophil-Mediated Destruction of Cultured Endothelial Cells. J. Clin. Invest. 1981; 68: 714-721.
  9. Root RK, Metcalf J, Oshino N, et al: H2O2     Release from Human Granulocytes during Phagocytosis. J. Clin. Invest. 1975; 55:945-955.
  10. Root RK and Metcalf JA: H2O2    Release from Human Granulocytes during Phagocytosis. J. Clin. Invest. 1977 ;60: 1266-1279.
  11. Ramasarma T: Generation of H2O2  in Biomembranes. Biochemica et Biophysica ACTA 1982; 694: 69-93.
  12. Garner MH, Garner WH, Spector A: Kinetic Cooperativity Change after H2O2    Modification of (Na,K)-ATPase, J. Biolog. Chem. 1984; 259: 7712-7718.
  13. Wildberger E, Kohler H, Jenzer H, et al: Inactivation of Peroxidase and Glucose Oxidase by H2O2  and Iodide during In Vitro Thyroglobulin Iodination. Mol Cell Endocrinol 1986; 46(2): 149-154.
  14. Swaroop A and Ramasarma T: Heat Exposure and Hypothyroid Conditions Decrease Hydrogen Peroxide Production Generation in Liver Mitochrondia. J. Biochem. 1985; 226(2): 403-8.
  15. Nelson DH and Murray DK: Dexamethasone Inhibition of Hydrogen Peroxide-stimulated Glucose Transport. Endocrinology 1987; 120(1): 156-159.
  16. Helm AU and Gunn J: The Effect of Insulinomimetic Agents on Protein Degradation in H-35 Hepatoma Cells. Mol. Cell. Biochem. 1986; 71(2): 159-166.
  17. Jay BE, Finney JW, Balla GA, et al. The Supersaturation of Biologic Fluids with Oxygen by the Decomposition of Hydrogen Peroxide. Texas Rpts. Biol and Med 1964; 22: 106-109.
  18. Balla GA, Finney JW, Aronoff BL, et al: Use of Intraarterial Hydrogen Peroxide to Promote Wound Healing. An J. Surg. 1964; 108:621-629.
  19. Fuson RL, Kylstra JA, Hochstein P, et al: Intravenous Hydrogen Peroxide Infusion as a Means of Extrapulmonary Oxygenation. Clin. Res. 1967;15: 74.
  20. Finney JW, Balla GA, Race GJ, et al: Peripheral Blood Changes in Humans and Experimental Animals Following the Infusion of Hydrogen Peroxide into the Carotid Artery. Angio 1965; 16:62-66.
  21. Mallams JT, Finney JW, and Balla GA: The Use of Hydrogen Peroxide As A Source of Oxygen in A Regional Intra-Arterial Infusion System. So. M.J. 1962; 55: 230-232.
  22. Lorincz AL, Jacoby JJ, Livingstone MM: Studies on the Parenteral Administration of Hydrogen Peroxide. Anesthesiology 1948; 9: 162-174.
  23. Rowley DA and Halliwell B: Formation of Hydroxyl Radicals from Hydrogen Peroxide and Iron Salts by Superoxide and Ascorbate-dependent Mechanisms: Relevance to the Pathology of Rheumatoid Disease. Clin. Sci. 1983; 64: 649-653.
  24. MacNaughton JI: Regional Oxygenation and Radiotherapy: A Study of the Degradation of Infused Hydrogen Peroxide. II. Measurement of Decomposition of H2O2  Infused Into Flowing Blood. Int. J. Radiat. Biol. 1971; 19: 415-426.
  25. MacNaughton JI: Regional Oxygenation and Radiotherapy: A Study of the Degradation of Infused Hydrogen Peroxide. I. Infusate Mixing. Int. J. Radiat. Biol. 1971; 19: 405-413
  26. Snyder LM, Fortier NL, Trainor J, et al: Effect of Hydrogen Peroxide Exposure on Normal Human Erythrocyte Deformability, Morphology, Surfact Characteristics, and Spectrin-Hemoglobin CrossLinking. J. Clin. Invest. 1985; 76: 1971-1977.
  27. Minotti G and Aust SD: The Requirement for Iron (III) in the Initiation of Lipid Peroxidation by Iron(II) and Hydrogen Peroxide. J. Biol. Chem. 1987: 262(3):1098-104.
  28. Farr CH: Possible Therapeutic Value of Intravenous Hydrogen Peroxide. Second International Symposium; Chelating Agents in Pharmacology, Toxicology and Therapeutics 1987; Charles University, Pilsen, Czechoslovak (In press).
  29. Diez-Marques ML, Lucio-Cazana FJ and Rodriguez Puyol M: In-vitro Response of Erythrocytes to Alphatocopherol Exposure. Int. J. Vita., Nutr., Res 1986; 56(3): 311-315.
  30. Johnson RJR, Froese G, Khodadad M, et al: Hydrogen Peroxide and radiotherapy. Bubble Formation in Blood. Br. J. Radiol. 1968; 41: 749-754.
  31. Farr CH: The Therapeutic Use of Intravenous Hydrogen Peroxide (Monograph). Genesis Medical Center, Oklahoma City, OK 73120, Jan. 1987.
  32. Finney JW, Jay BE, Race GJ, et al: Removal of Cholesterol and Other Lipids from Experimental Animal and Human Atheromatous Arteries by Dilute Hydrogen Peroxide. Angiology 1966; 17: 223-228.
  33. Urschel HE Jr: Cardiovascular Effects of Hydrogen Peroxide: Current Status. Dis. of Chest 1967; 51:180192.
  34. Finney JW, Balla GA, Race GJ, et al: Peripheral Blood Changes in Humans and Experimental Animals Following the Infusion of Hydrogen Peroxide into the Carotid Artery. Angio. 1965; 16: 62-66.
  35. Finney JW, Urschel HC, Balla GA, et al: Protection  of the Ischemic Heart with DMSO Alone or DMSO with Hydrogen Peroxide. Ann. NY Acad. Sci. 1967; 151: 231-241.
  36. Urschel HC, Finney JW, Morale AR, et al: Cardiac Resuscitation with Hydrogen Peroxide. Circ. 1965; 31 (suppl II); II-210.
  37. Ackerman NB, Brinkley FB: Comparison of Effects on Tissue Oxygenation of Hyperbaric Oxygen and Intravascular Hydrogen Peroxide. Sur. 1968; 63: 285290.
  38. Germon PA, Faust DS, Brady, LW: Comparison of Arterial and Tissue Oxygen Measurements in Humans Receiving Regional Hydrogen Peroxide Infusions and Oxygen Inhalation. Radiology 1968; 91: 669-672.
  39. Germon PA, Faust DS, Rosenthal A, et al: Regional Arterial and Tissue Oxygen Tensions in Man During Regional Infusion with Hydrogen Peroxide Solutions. Radiology 1967; 88:589-591.
  40. Farr CH: Physiological and Biochemical Responses to Intravenous Hydrogen Peroxide in Man. J. ACAM 1987; (In Press).
  41. Hothersall JD, Greenbaum AL, McLean P: The Functional Significance of the Pentose Phosphate Pathway in Synaptosomes: Protection Against Peroxidative Damage by Catecholamines and Oxidants. J. Neurochem. 1982; 39:13252.
  42. Cranne D, Haussinger D, Sies H: Rise of Coenzyme A-Glutathione Mixed Disulfide during Hydroperoxide Metabolism in Perfused Rat Liver. Euo. J. Biochem. 1982; 127: 575-578.
  43. Wrigglesworth JM: Formation and Reduction of a 'Peroxy' Intermediate of Cytochrome C Oxidase by Hydrogen Peroxide. Biochem. J. 1984; 217; 715-719.
  44. Gorren AC, Dekker H and Wever R: Kinetic Investigations of the Reactions of Cytochrome C Oxidase with Hydrogen Peroxide. Biochem. Biophys. Acta. 1986; 852(1): 81-92.
  45. Del Maestro RF, Thaw HH, BjorkJ, et al: Free Radicals as Mediators of Tissue Injury. Acta Physiol. Scand. 1980; 492 (supple): 43-57.
  46. Yamaja Setty BN, Jurek E, Ganley C, et al: Effects of Hydrogen Peroxide on Vascular Arachidonic Acid Metabolism. Prostag. Leuko. Med 1984; 14: 205-213.
  47. Polgar P, Taylor L: Stimulation of Prostaglandin Synthesis by Ascorbic Acid via EIydrogen Peroxide Formation. Prostag 1980; 19:693.
  48. Marshall PJ and Lands WE: In Vitro Formation of Activators for Prostaglandin Synthesis by Neutrophils and Macrophages from Humans and Guinea Pigs. J. Lab. Clin. Med. 1986; 108 (6) :525-534.
  49. Tappel AL: Lipid Peroxidation Damage to Cell Component. Fed Proc. 1973; 32:1870.
  50. Shimada O and Yashuda H: Lipid Peroxidation and its Inhibition by Tinoridine. Biochem. Biophys. ACTA 1979; 572:531.
  51. Morehouse LA, Tien M, Bucher JR, et al: Effect of Hydrogen Peroxide on the Initiation of Microsomal Lipid Peroxidation. Biochem. Pharm. 1983; 32:123-127.
  52. Harrison JF and Schultz J: Studies on the Chlorinating Activity of Myeloperoxidase. J. Biol. Chem. 1976; 251:13711374.
  53. ZgliczynskiJM, Selvaraj RJ, Paul BB, et al: Chlorination by the Myeloperoxidase-H2O2 -C1 antimicrobial system at Acid and Neutral pH. Proc. Soc. Exp. Biol. Med. 1977; 154: 418422.
  54. Kiebanoff SJ: Oxygen Metabolism and the Toxic Properties of Phagocytes. Ann. Intern. Med. 1980; 93: 480-489.
  55. Slivka A, LoBuglio AF, Weiss SJ: A Potential  Role for Hypochlorous Acid in Granulocyte-Mediated Tumor Cell Cytotoxicity. Blood 1980; 55: 347-350.
  56. Thomas EL: Myeloperoxidase, Hydrogen Peroxide, Chloride Antimicrobial System: Nitrogen-Chlorine Derivatives of Bacterial Components in Bacterial Action against Eschericia coli. Infec. Immun.  1979; 23: 522-531.
  57. Nathan CF and Cohn ZA: Antitumor Effects of Hydrogen Peroxide in Vivo. J. Exp. Med. 1981; 154:1539-1553.
  58. Munakata T, Semba U, Shibuya Y, et al: Induction of Interferon-gamma Production by Human Natural Killer Cells Stimulated by Hydrogen Peroxide. J. Immunol. 1985; 134(4): 2449-2455.
  59. Lebedev LV, Levin AO, Romankova MP, et al: Regional Oxygenation in the Treatment of Severe Destructive Forms of Obliterating Diseases of the Extremity Arteries. VestnKhir 1984;132:85-88.
  60. Gusak VK, Klioner LI, Belinski VE, et al: Possibilities of Using Weak Solutions of Hydrogen Peroxide in the Treatment of Experimental Ischemia of the Lower Extremities. Klin Khir 1986; 7:31-33.
  61. Urschel HC, Finney JW, Dyll LM, et al: Treatment of Artheriosclerotic Obstructive Cerebrovascular Disease with Hydrogen Peroxid. Vas. Serg. 1967; 1:77-81.
  62. Jepras RI and Fitzgeorge RB: The Effect of Oxygendependent Antimicrobial Systems on Strains of Legionella Pneumophila of Different Virulence. J. Hyg. (Lond) 1986; 97(1):61-9.
  63. Steiner BM, Wong GH, Sutrave P, et al: Oxygen Toxicity in Treponema Pallidum: Deoxyribonucleic Acid Singlestranded Breakage Induced by Low Doses of Hydrogen Peroxide. Can. J. Microbiol. 1984; 30 (12): 1467-76.
  64. Brandi G, Sestili P, Pedrini MA, et al: The Effect of Temperature or Anoxia on Escherichia Coli Killing Induced by Hydrogen Peroxide. Mutat Res. 1987; 190(4): 23740.
  65. Norkus EP, Kuenzig W, Conney AH: Studies on the Mutagenic Activity of Ascorbic Acid in Vitro and in Vivo. Mutat. Res. 1983; 117(1): 183-9.
  66. Klebanoff SJ and Shepard CC: Toxic Effect of the Peroxidase-hydrogen peroxide-halide Antimicrobial System on Mycobacterium leprae. Infect. Immun. 1984; 44(2): 534-6.
  67. Miller SA, Bia FJ, Coleman DL, et al: Pulmonary Macrophage Function During Experimental Cytomegalovirus Interstitial Pneumonia. Infect. Immun. 1985; 47(1): 211-6.
  68. Belotskii SM, Filiudova OB, Pashutin SB, et al: Chemiluminescence of Human Neutrophils as Affected by Opportunistic Microbes. Zh. Mikrobiol. Epidemiol. Immunobiol. 1986; Mar (3): 89-92.
  69. Moran AP and Upton ME: Effect of Medium Supplements, Illumination and Superoxide Dismutase on the Production of Coccoid Forms of Campylobacter jejuni ATCC29428. J. Appl. Bacteriol. 1987; 62(1): 43-51.
  70. Looney RJ and Steigbigel RT: Role of the Vi Antigen of Salmonella typhi in Resistance to Host Defense  In Vitro. J. Lab. Clin. Med. 1986; 108(5): 506-16.
  71. Wilson CB and Weaver WM: Comparative Susceptibility of Group B Streptococci and Staphylococcus aureus to Killing by Oxygen Metabolites. J. Infect. Dis. 1985; 152(2): 32-9.
  72. Tenovuo J, Makinen K, Sievers G: Antibacterial Effect of Lactoperoxidase and Myeloperoxidase Against Bacillus cereus. Antimicrob. Agents Chemother. 1985; 27(1): 96-101.
  73. Miyasaki KT, Wilson ME, Genco RJ: Killing of Actinobacillus actinomycetemcomitans by the Human Neutrophil Myeloperoxidase-hydrogen peroxidechloride System. Infect. Immun. 1986; 53(1): 161-5.
  74. Rotstein OD, Nasmith PE, Grinstein S: The Bacteroides Byproduct Succinic Acid Inhibits Neutrophil Respiratory Burst by Reducing Intracellular pH. Infect. Immun. 1987; 55(4): 864-70.
  75. Archibald FS and Duong MN: Superoxide Dismutase and Oxygen Toxicity Defenses in the Genus Neisseria. Infect. Immun. 1986; 51 (2): 63141.
  76. Howard DH: Studies on the Catalase of Histoplasma Capsulatum. Infect. Iminun. 1983; 39(3):1161-6.
  77. Sasada M, Kubo A, Nishimura T, et al: Candidacidal Activity of Monocyte-derived Human Macrophages: Relationship between Candida Killing and Oxygen Radical Generation by Human Macrophages. J. Leukocyte Biol. 1987; 41 (4): 289-94.
  78. Schaffner A, Davis CE, Schaffner T, et al: In Vitro Susceptibility of Fungi to Killing by Neutrophil Granulocytes Discriminates Between Primary Pathogenicity and Opportunism. J. Clin. Invest. 1986; 78(2): 511-24.
  79. Levitz SM and Diamond RD: Mechanisms of Resistance of Aspergillus fumugatus Conidia to  Killing by Neutrophils In Vitro. J. Infect. Dis. 1985; 152(1): 3342.
  80. Galgiani JN: Inhibition of Different Phases of Coccidiodides immitis by lIuman Neutrophils or Hydrogen Peroxide. J. Infect. Dis. 1986:153(2): 21-22.
  81. Pesanti EL: Pneumocystis Carinii: Oxygen Uptake, Antioxidant Enzymes, and Susceptibility to Oxygenmediated Damage. Infect. Immun. 1984; 44(1): 7-11.
  82. Brinkmann V, Kaufmann SH, Simon MM, et al: Role of Macrophages in Malaria: 02 Metabolite Production and Phagocytosis by Splenic Macrophages During Lethal Plasmodium berghei and Self-limiting Plasmodium yoelii Infection in Mice. Infect. Immun. 1984; 44(3): 7434.
  83. Murray HW: Cellular Resistance to Protozoal Infection. Annu. Rev. Med. 1986; 37: 61-9.
  84. Paget TA, Fry M, Lloyd D: Effects of Inhibitors on the Oxy